Our investigation is pioneer to report immunohistochemical staining of leptin is considerably correlated with patients’ clinicopathological findings such as age, histotype, grade, stage, recurrence, lymph node involvement, hormone receptor phenotype, ER expression, HER2 expression and survival of patients with breast carcinoma. This evidence concerns the gene LEP and breast carcinoma.